A round-up of all the latest M&A, partnering and financing news within the life sciences.
Latest partnering news
BMS and Tsinghua University in structural biology research pact
May 15, 2012 : Big Pharma, Bristol-Myers Squibb, partnering
Bristol-Myers Squibb Company and Tsinghua University of Beijing, announced the formation of a multi-year strategic partnership more »
Menarini licenses rights to Priligy
May 15, 2012 : Big Pharma, licensing, Menarini, partnering
Furiex Pharmaceuticals and Menarini Group announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East more »
Bayer and Santen enter co-promotion agreement for Eylea injection in Japan
May 9, 2012 : Bayer, Big Pharma, co-promotion, partnering
Santen Pharmaceuticals negotiated co-promotion rights to Regeneron Pharmaceuticals and Bayer HealthCare’s Eylea (aflibercept; VEGF Trap-Eye) injection in Japan more »
Latest M&A news
Kensey Nash Sued by Investor Over $360 Million DSM Bid
May 14, 2012 : dealtalk, M&A
Kensey Nash, a maker of absorbable cardiac medical devices, was sued by a stockholder contending investors will be shortchanged in a planned $360 million bid from Royal DSM more »
Novartis acquires specialty dermatology company Fougera
May 4, 2012 : Big Pharma, M&A, Novartis
Novartis is buying specialty dermatology generics firm Fougera Pharmaceuticals for $1.525 billion in cash more »
Hologic acquires Gen-Probe for $3.7 billion
May 1, 2012 : M&A
Hologic and Gen-Probe announced that their Boards of Directors have unanimously approved a definitive agreement under which Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value of approximately $3.7 billion more »
Latest financing news
OncoMed seeks $115 million IPO
May 15, 2012 : financings
OncoMed offers $115M IPO bet on cancer stem cell work more »
Fresenius in public offering for $1.31 billion
May 14, 2012 : financings
Fresenius successfully completes capital increase more »
PROLOR Biotech announced the pricing of its previously announced underwritten public offering of 6.5 million shares of its common stock at a price to the public of $5.00 per share more »
Latest Dealtalk
Amag Pharma falls after ending sale talks
May 15, 2012 : dealtalk, M&A
Shares of Amag Pharmaceuticals Inc. sank Thursday, a day after the anemia drug maker said it is no longer considering selling itself more »
Kensey Nash Sued by Investor Over $360 Million DSM Bid
May 14, 2012 : dealtalk, M&A
Kensey Nash, a maker of absorbable cardiac medical devices, was sued by a stockholder contending investors will be shortchanged in a planned $360 million bid from Royal DSM more »
Can Pharma Turn the Oceanliner Around?
May 14, 2012 : Big Pharma
In introducing biotech guru G. Steven Burrill today, Illinois BIO (iBIO) president David Miller likened the speaker to the Michael Jordan of biotechnology. “There will never be the next Steven Burrill,” he said. “At a critical time in biotech’s development, he was there.” more »
